Axial Spondyloarthritis
- NSAID Use Associated With Lower Risk for MACE in Ankylosing Spondylitis
- Sex Differences Reported in Disease Outcomes Among Patients With Axial Spondyloarthritis
- Radiologic Features Compared Between Diffuse Idiopathic Skeletal Hyperostosis and AS
- Endophthalmitis Linked to Increased Risk for Acute Myocardial Infarction in AS
- Dual Inhibition of IL-17 With Bimekizumab Improves Efficacy Outcomes in axSpA
- Inflammation Associated With Radiographic Progression in AS
- Hematologic Malignancy Risk Higher Among Older Patients With AS
- Evidence Supports TNFi and IL-17i in the Treatment of axSpA
- Continuous Treatment With Ixekizumab Less Likely to Result in Flares in axSpA
- Upadacitinib Approved for Active nr-axSpA
- Prevalence of Axial Pain and Arthritis Assessed in IBD
- High Rate of Undiagnosed axSpA Among Patients With IBD
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
